Status report
Get it in writing
The official USPTO status record for TRUNEXUS, serial 85324117, as a dated PDF. One price, one document, delivered in about a minute.
INSTANT DELIVERY
Trademark Status Report
$7.99
The USPTO's own status record for this mark, on one dated page.
- Current status with a plain-English verdict
- Owner, classes, filing basis, and every key date
- The mark as it appears on the federal record
- Every prosecution event, filing to today
- Source-cited with the exact retrieval date
Built from the USPTO's TSDR record. Assignment chain of title and TTAB proceeding files sit in separate USPTO systems and are not included.
Preview
◆ TRADEMARKCHECKER.AITRADEMARK STATUS REPORT
TRUNEXUSSerial 85324117 · Principal Register
Dead · Refused
Owner: Eli Lilly and Company
Class 005 - Pharmaceuticals
Filed May 18, 2011
The record shows that “TRUNEXUS” is an abandoned application (status dead) that was filed by Eli Lilly and Company on May 18 2011 and finally abandoned on June 29 2015 after no Statement of Use was filed following the Notice of Allowance. The only goods listed are in International Class 5 and cover a long series of veterinary and animal‑feed pharmaceuticals, such as insecticides for livestock, veterinary treatments for infectious and metabolic diseases, dietary supplements for animals, and various antimicrobials used in food‑animal processing. Because the protection was limited to those specific pharmaceutical and animal‑health products, a similar name used for unrelated goods—say, software, clothing, or consumer electronics—would be far from the scope shown here, though the same wording in the same field could raise a record‑based concern. The prosecution history shows a series of extensions for filing a Statement of Use, but none succeeded, leading to the abandonment; the mark never reached the Supplemental Register. The latest meaningful event is the abandonment notice on June 29 2015, and the supplied history contains no opposition, cancellation, or other enforcement actions. I'd treat this as a moderate concern only if you plan to market veterinary or animal‑feed pharmaceuticals under a similar name.
Full event history, owner details, and verdict inside.
The way I'd use it, honestly, is as the thing you attach when a bank, a marketplace, or a co-founder asks "are we clear on the name". It answers in one page.